BENITEC BIOPHARMA LTD's ticker is BNTCW and the CUSIP is 082053117. A total of 2 filers reported holding BENITEC BIOPHARMA LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,000 | 0.0% | 51,449 | -9.7% | 0.00% | 0.0% |
| Q2 2019 | $1,000 | -83.3% | 56,949 | -1.7% | 0.00% | -66.7% |
| Q1 2019 | $6,000 | -14.3% | 57,949 | -0.2% | 0.00% | +50.0% |
| Q4 2018 | $7,000 | 0.0% | 58,050 | 0.0% | 0.00% | +100.0% |
| Q3 2018 | $7,000 | -12.5% | 58,050 | -23.5% | 0.00% | 0.0% |
| Q2 2018 | $8,000 | -81.0% | 75,904 | -56.7% | 0.00% | -66.7% |
| Q1 2018 | $42,000 | +16.7% | 175,386 | +94.5% | 0.00% | 0.0% |
| Q4 2017 | $36,000 | +33.3% | 90,193 | 0.0% | 0.00% | +50.0% |
| Q3 2017 | $27,000 | -15.6% | 90,193 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $32,000 | -13.5% | 90,193 | -27.9% | 0.00% | 0.0% |
| Q1 2017 | $37,000 | +270.0% | 125,163 | +27.5% | 0.00% | +100.0% |
| Q4 2016 | $10,000 | -41.2% | 98,146 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $17,000 | -29.2% | 98,146 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $24,000 | -76.0% | 98,146 | -1.4% | 0.00% | -80.0% |
| Q1 2016 | $100,000 | -49.7% | 99,555 | 0.0% | 0.01% | -54.5% |
| Q4 2015 | $199,000 | +39.2% | 99,555 | -74.6% | 0.01% | +83.3% |
| Q3 2015 | $143,000 | – | 391,826 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 90,193 | $32,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 50,000 | $18,000 | 0.00% |
| UBS Group AG | 385 | $0 | 0.00% |